Steven Cohen acquired 484k Veracyte shares worth $22.9M. That's 0.04% of their equity portfolio (483rd largest holding). The first Veracyte trade was made in Q1 2019. Since then Steven Cohen bought shares eight more times and sold shares on ten occasions. The stake costed the investor $19.4M, netting the investor a gain of 18% so far.